Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05556629 · ClinicalTrials.gov registry record
A Survey to Assess Participants' and Physicians' Knowledge, Attitudes and Behavior When Using NATPARA
A clinical trial, sponsored by Shire.
- Completed
- Registry status
- 200
- Enrollment target
NCT05556629 is a clinical trial that has completed, run by Shire. The registered enrollment target is 200 participants.
The verdict
NCT05556629 has completed, sponsored by Shire.
- COMPLETED
- Registry status
- 200 participants
- Enrollment target
Study Summary
This main aim of this study is to check the level of knowledge and assess attitudes and behaviors of both participants and prescribing physicians regarding the risks and safe use of NATPARA. The survey will be done via internet, telephone, or paper and participants will be able to choose the method that is preferred. No study medicines will be provided to patients in this study.
Interventions
- OTHER No Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2015-09-01 |
| Est. Completion | 2025-11-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05556629
The ClinicalTrials.gov registry entry for NCT05556629 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Shire, which has 245 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which No Intervention is the first listed.
NCT05556629 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05556629 about?
NCT05556629 is a clinical study titled "A Survey to Assess Participants' and Physicians' Knowledge, Attitudes and Behavior When Using NATPARA". This main aim of this study is to check the level of knowledge and assess attitudes and behaviors of both participants and prescribing physicians regarding the risks and safe use of NATPARA. The survey will be done via internet, telephone, or paper and participants will be able to choose the method ...
What is the current status of trial NCT05556629?
This trial is currently completed. The enrollment target is 200 participants. The study started on 2015-09-01. Estimated completion is 2025-11-30.
What interventions are being tested in trial NCT05556629?
The interventions under investigation include: No Intervention (OTHER).
Who is sponsoring clinical trial NCT05556629?
This trial is sponsored by Shire, which has 245 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.